tiprankstipranks
Trending News
More News >
Protagenic Therapeutics (PTIX)
OTHER OTC:PTIX
US Market

Protagenic Therapeutics (PTIX) Financial Statements

Compare
93 Followers

Protagenic Therapeutics Financial Overview

Protagenic Therapeutics's market cap is currently $1.00M. The company's EPS TTM is $-15.832; its P/E ratio is -0.07; Protagenic Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -50.29K$ -28.22K$ -30.00$ 0.00$ -286.00
Operating Income$ -5.70M$ -4.53M$ -3.56M$ -4.14M$ -2.55M
EBITDA$ -5.47M$ -4.50M$ -3.42M$ -4.14M$ -2.55M
Net Income$ -5.53M$ -5.00M$ -3.56M$ -4.52M$ -2.55M
Balance Sheet
Cash & Short-Term Investments$ 1.84M$ 4.06M$ 7.98M$ 10.37M$ 671.09K
Total Assets$ 1.96M$ 4.32M$ 8.04M$ 11.06M$ 879.25K
Total Debt$ 0.00$ 0.00$ 344.23K$ 318.43K$ 1.37M
Net Debt$ -1.84M$ -1.29M$ 129.04K$ -222.74K$ 702.71K
Total Liabilities$ 942.76K$ 655.25K$ 1.12M$ 1.12M$ 2.03M
Stockholders' Equity$ 1.01M$ 3.67M$ 6.92M$ 9.94M$ -1.15M
Cash Flow
Free Cash Flow$ -4.22M$ -3.85M$ -2.00M$ -2.80M$ -1.35M
Operating Cash Flow$ -4.22M$ -3.70M$ -1.99M$ -2.80M$ -1.35M
Investing Cash Flow$ 2.80M$ 4.78M$ 1.60M$ -9.91M$ 0.00
Financing Cash Flow$ 1.96M$ 0.00$ 0.00$ 12.58M$ 1.22M
Currency in USD

Protagenic Therapeutics Earnings and Revenue History

Protagenic Therapeutics Debt to Assets

Protagenic Therapeutics Cash Flow

Protagenic Therapeutics Forecast EPS vs Actual EPS